Mirna Therapeutics Company Profile (NASDAQ:MIRN)

About Mirna Therapeutics

Mirna Therapeutics logoMirna Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of microRNA (ribonucleic acid)-based oncology therapeutics. It is developing a cancer therapy, microRNA Replacement Therapy, focused on replacing naturally occurring microRNAs that are under expressed in cancer cells with microRNA mimics. Its pipeline of products includes MRX34, miR-101, miR-215, let-7 and miR-16. The Company's lead product candidate, MRX34, a mimic of naturally occurring microRNA-34 (miR-34), is in Phase I clinical trial in patients with primary liver cancer, advanced solid tumors and hematological malignancies. Its miR-34 is considered a key regulator of multiple oncogenes across key oncogenic pathways. The Company focuses on developing MRX34 as a monotherapy and in combination with other therapeutic modalities, such as targeted therapies and immuno-oncology agents.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MIRN
  • CUSIP:
Key Metrics:
  • Previous Close: $3.06
  • 50 Day Moving Average: $4.056
  • 200 Day Moving Average: $4.337
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.72
  • P/E Growth: 0.000
  • Market Cap: $63.73M
  • Outstanding Shares: 20,835,000
Additional Links:
Companies Related to Mirna Therapeutics:

Analyst Ratings

Consensus Ratings for Mirna Therapeutics (NASDAQ:MIRN) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $8.88 (190.13% upside)

Analysts' Ratings History for Mirna Therapeutics (NASDAQ:MIRN)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016Oppenheimer Holdings Inc.Boost Price TargetOutperform$7.00 -> $13.00View Rating Details
8/16/2016Citigroup Inc.DowngradeBuy -> Neutral$7.00 -> $4.50View Rating Details
8/15/2016Leerink SwannDowngradeOutperform -> Market Perform$10.00 -> $4.00View Rating Details
5/13/2016Cantor FitzgeraldReiterated RatingBuy$14.00View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Mirna Therapeutics (NASDAQ:MIRN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/11/2016        
11/13/2015Q315($82.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mirna Therapeutics (NASDAQ:MIRN)
Current Year EPS Consensus Estimate: $-1.350 EPS
Next Year EPS Consensus Estimate: $-1.780 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.43)($0.43)($0.43)
Q2 20162($0.50)($0.43)($0.47)
Q3 20162($0.46)($0.38)($0.42)
Q4 20162($0.59)($0.46)($0.53)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Mirna Therapeutics (NASDAQ:MIRN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mirna Therapeutics (NASDAQ:MIRN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/6/2015Michael PowellDirectorBuy857,142$7.00$5,999,994.00View SEC Filing  
10/6/2015Pfizer Incmajor shareholderBuy714,285$7.00$4,999,995.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Mirna Therapeutics (NASDAQ:MIRN)
DateHeadline
finance.yahoo.com logoMirna Therapeutics downgraded by Leerink Partners (NASDAQ:MIRN)
finance.yahoo.com - August 16 at 6:20 PM
reuters.com logoBRIEF-Mirna Therapeutics qtrly net loss attributable to common stockholders $5.64 mln (NASDAQ:MIRN)
www.reuters.com - August 15 at 8:24 AM
News IconMirna Therapeutics Reports Second Quarter 2016 Financial Results and Program Updates (NASDAQ:MIRN)
ih.advfn.com - August 15 at 8:24 AM
4-traders.com logoMIRNA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:MIRN)
www.4-traders.com - August 15 at 8:24 AM
sg.finance.yahoo.com logoMirna Therapeutics reports 2Q loss (NASDAQ:MIRN)
sg.finance.yahoo.com - August 15 at 8:23 AM
businesswire.com logomiRagen Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference (NASDAQ:MIRN)
www.businesswire.com - August 11 at 9:21 AM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:MIRN)
biz.yahoo.com - July 6 at 5:19 PM
publicnow.com logoMirna Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:MIRN)
www.publicnow.com - July 5 at 7:21 AM
finance.yahoo.com logoMirna Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:MIRN)
finance.yahoo.com - July 5 at 7:00 AM
4-traders.com logoMIRNA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:MIRN)
www.4-traders.com - July 1 at 6:11 PM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a V (NASDAQ:MIRN)
biz.yahoo.com - June 30 at 5:30 PM
publicnow.com logoMirna Therapeutics Appoints Perry Nisen, M.D., Ph.D., to Its Board of Directors (NASDAQ:MIRN)
www.publicnow.com - June 30 at 7:21 AM
capitalcube.com logoMirna Therapeutics, Inc. :MIRN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 (NASDAQ:MIRN)
www.capitalcube.com - June 8 at 6:07 PM
publicnow.com logoMirna Therapeutics Announces Clinical Data on its Lead microRNA Therapeutic Presented at ASCO (NASDAQ:MIRN)
www.publicnow.com - June 6 at 12:28 PM
bizjournals.com logoAustin-area Public Companies list (NASDAQ:MIRN)
www.bizjournals.com - June 3 at 8:58 AM
marketwired.com logoMarina Biotech Announces Resignation of Chairman, President and Chief Executive Officer J. Michael French (NASDAQ:MIRN)
www.marketwired.com - June 2 at 6:32 PM
tmcnet.com logomiRagen Therapeutics Receives ALS Association Grant to Advance the Development of MRG-107 (NASDAQ:MIRN)
www.tmcnet.com - June 2 at 9:04 AM
News IconMirna Therapeutics, Inc. (MIRN) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:MIRN)
www.sharetrading.news - May 30 at 7:20 PM
sg.finance.yahoo.com logoMirna Therapeutics reports 1Q loss (NASDAQ:MIRN)
sg.finance.yahoo.com - May 12 at 6:52 PM
publicnow.com logoMirna Therapeutics Reports First Quarter 2016 Financial Results and Program Updates (NASDAQ:MIRN)
www.publicnow.com - May 12 at 5:27 PM
marketwired.com logoMarina Biotech Terminates Negotiations for Sale of Its Nucleic Acid Therapeutic Assets (NASDAQ:MIRN)
www.marketwired.com - May 3 at 11:35 AM
4-traders.com logoMIRNA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) (NASDAQ:MIRN)
www.4-traders.com - April 27 at 12:31 PM
publicnow.com logoMirna Therapeutics Appoints Vincent J. O'Neill, M.D., as Chief Medical Officer (NASDAQ:MIRN)
www.publicnow.com - April 25 at 7:25 AM
finance.yahoo.com logoMirna Therapeutics Appoints Vincent J. O’Neill, M.D., as Chief Medical Officer (NASDAQ:MIRN)
finance.yahoo.com - April 25 at 7:00 AM
News IconMARINA BIOTECH CMN (OTCMKTS:MRNA) Shorts Decreased by 45.93% After Short Covering (NASDAQ:MIRN)
www.bibeypost.com - April 22 at 12:25 PM
finance.yahoo.com logo8:52 am Mirna Therapeutics announces results in 2 data presentations at the annual meeting of the American Association for Cancer Research (NASDAQ:MIRN)
finance.yahoo.com - April 20 at 8:52 AM
publicnow.com logoMirna Therapeutics Announces Data Presentations at the Annual Meeting of the American Association for Cancer Research (NASDAQ:MIRN)
www.publicnow.com - April 20 at 8:51 AM
benzinga.com logoAnalyst Highlights Regulus Therapeutics' 'Disruptive 2016 Catalysts' (NASDAQ:MIRN)
www.benzinga.com - April 13 at 11:41 AM
finance.yahoo.com logoMIRNA THERAPEUTICS, INC. Financials (NASDAQ:MIRN)
finance.yahoo.com - April 2 at 1:04 PM
finance.yahoo.com logoMarina Biotech Provides 2015 Year-End Financials and Update (NASDAQ:MIRN)
finance.yahoo.com - March 31 at 10:48 AM
bizjournals.com logoAustin biotech firm's IPO for cancer drugs may not be as big as originally thought (NASDAQ:MIRN)
www.bizjournals.com - March 30 at 10:52 AM
4-traders.com logoMIRNA THERAPEUTICS : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:MIRN)
www.4-traders.com - March 30 at 10:52 AM
seekingalpha.com logoMirna Therapeutics's (MIRN) CEO Paul Lammers on Q4 2015 Results - Earnings Call Transcript (NASDAQ:MIRN)
seekingalpha.com - March 30 at 10:52 AM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report (NASDAQ:MIRN)
biz.yahoo.com - March 30 at 6:21 AM
publicnow.com logoMirna Therapeutics Provides Operational Update and Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2015 (NASDAQ:MIRN)
www.publicnow.com - March 29 at 4:24 PM
4-traders.com logoMIRNA THERAPEUTICS : to Host Conference Call and Webcast of Fourth Quarter and.. (NASDAQ:MIRN)
www.4-traders.com - March 22 at 10:50 AM
publicnow.com logoMirna Therapeutics to Host Conference Call and Webcast of Fourth Quarter and Full Year 2015 Financial Results on March 29, 2016 (NASDAQ:MIRN)
www.publicnow.com - March 22 at 8:05 AM
finance.yahoo.com logoMarina Biotech Announces a License Agreement to Deliver a Genome Editing Technology (NASDAQ:MIRN)
finance.yahoo.com - March 16 at 8:30 AM
msn.com logoMicrolin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech (NASDAQ:MIRN)
www.msn.com - March 15 at 10:39 AM
thestreet.com logoRosetta Genomics Appoints Ana C. Ward As Executive Vice President, Legal And Corporate Development (NASDAQ:MIRN)
www.thestreet.com - February 29 at 10:04 AM
finance.yahoo.com logoMarina Biotech Announces Evaluation and Option Agreement to Deliver a Genome Editing Technology (NASDAQ:MIRN)
finance.yahoo.com - February 18 at 8:30 AM
finance.yahoo.com logoMarina Biotech to Explore Strategic Alternatives (NASDAQ:MIRN)
finance.yahoo.com - February 17 at 9:44 AM
finance.yahoo.com logoMirna Therapeutics to Present at the BIO CEO & Investor and LEERINK Global Healthcare Conferences in February (NASDAQ:MIRN)
finance.yahoo.com - February 3 at 7:00 AM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi (NASDAQ:MIRN)
biz.yahoo.com - February 1 at 4:17 PM
publicnow.com logoMirna Therapeutics Appoints Peter Greenleaf to Its Board of Directors (NASDAQ:MIRN)
www.publicnow.com - February 1 at 7:30 AM
noodls.com logoRosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the Development of Oncology Therapeutics (NASDAQ:MIRN)
www.noodls.com - January 6 at 6:27 PM
noodls.com logoMirna Therapeutics Announces the Publication of New Data Supporting Potential Immune-Related Mechanism for Anti-Cancer Activity of MRX34 (NASDAQ:MIRN)
www.noodls.com - November 23 at 10:29 AM
noodls.com logoMirna Therapeutics Reports Third Quarter Financial Results and Recent Highlights (NASDAQ:MIRN)
www.noodls.com - November 13 at 7:26 AM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (NASDAQ:MIRN)
biz.yahoo.com - November 13 at 7:02 AM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:MIRN)
biz.yahoo.com - November 13 at 6:17 AM

Social

Mirna Therapeutics (NASDAQ:MIRN) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff